xolair log in

xolair log in

Searching for xolair log in? Use official links below to sign-in to your account.

If there are any problems with xolair log in, check if password and username is written correctly. Also, you can contact with customer support and ask them for help. If you don't remember you personal data, use button "Forgot Password". If you don't have an account yet, please create a new one by clicking sign up button/link.

Allergic Asthma and CIU Treatment | XOLAIR® (Omalizumab)

    https://www.xolair.com/
    XOLAIR (omalizumab) for subcutaneous use is a prescription treatment for moderate to severe persistent allergic asthma not controlled with ICS and chronic idiopathic urticaria (CIU) in appropriate patients. See full safety & Boxed Warning
    Status:Page Online
    https://www.xolair.com/

XOLAIR Co-pay Program

    https://www.xolaircopay.com/
    What is XOLAIR? XOLAIR ® (omalizumab) for subcutaneous use is an injectable prescription medicine used to treat:. moderate to severe persistent asthma in patients 6 years of age or older whose asthma symptoms are not controlled by asthma medicines called inhaled corticosteroids.
    Status:Page Online
    https://www.xolaircopay.com/

XOLAIR Access Solutions | XOLAIR® (omalizumab) for ...

    https://www.genentech-access.com/hcp/brands/xolair.html
    Learn about XOLAIR Access Solutions, a resource that provides reliable, effective access and reimbursement support to assist your patients and practice after XOLAIR® (omalizumab) for subcutaneous use has been prescribed.
    Status:Page Online
    https://www.genentech-access.com/hcp/brands/xolair.html

Xolair - FDA prescribing information, side effects and uses

    https://www.drugs.com/pro/xolair.html
    Xolair is indicated for patients 6 years of age and older with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. Xolair has been shown to decrease the incidence of asthma exacerbations in these patients.
    Status:Page Online
    https://www.drugs.com/pro/xolair.html

Preparation and Administration - XOLAIR (omalizumab)

    https://www.xolairhcp.com/starting-treatment/administration.html
    XOLAIR is administered subcutaneously every 2 or 4 weeks for Allergic Asthma and every 4 weeks for CIU. 1 Because the solution is slightly viscous, the injection may take 5 to 10 seconds to administer. XOLAIR injections may be administered in your office or at an appropriate injection facility that administers XOLAIR.
    Status:Page Online
    https://www.xolairhcp.com/starting-treatment/administration.html

CIU Support Program Sign Up | XOLAIR® (Omalizumab)

    https://www.xolair.com/ciu/ciu-treatment-resources/sign-up.html
    Register for Support For You! Fill out the form below to get helpful information about treatment with XOLAIR *All fields are required unless marked as optional. Questions About You. ... Do not receive XOLAIR if you are allergic to omalizumab or any of the ingredients in XOLAIR.
    Status:Page Online
    https://www.xolair.com/ciu/ciu-treatment-resources/sign-up.html

XOLAIR Forms & Documents | XOLAIR Access Solutions

    https://www.genentech-access.com/hcp/brands/xolair/forms-and-documents.html
    Forms and Documents. We've made enrollment simpler, faster and more intuitive with some key changes to our forms. The Prescriber Service Form and the Patient Consent Form are required for enrollment in Genentech Access Solutions. These forms replace the Statement of Medical Necessity (SMN) and the Patient Authorization and Notice of Request for Transmission of Health Information to Genentech ...
    Status:Page Online
    https://www.genentech-access.com/hcp/brands/xolair/forms-and-documents.html

Chronic Idiopathic Urticaria Treatment - XOLAIR (omalizumab)

    https://www.xolairhcp.com/chronic-idiopathic-urticaria.html
    Chronic idiopathic urticaria (CIU) affects approximately 1.5 million people in the United States. 14,18 About 50% of CIU patients continue to experience itch and hives despite H1 antihistamine treatment at FDA-approved doses. 18,19 For patients experiencing symptoms of CIU, H1 antihistamines may not be enough to relieve their symptoms.
    Status:Page Online
    https://www.xolairhcp.com/chronic-idiopathic-urticaria.html

Injection: 75 mg/0.5 mL and 150 mg/mL solution in a single ...

    https://www.gene.com/download/pdf/xolair_prescribing.pdf
    XOLAIR is not indicated for treatment of other forms of urticaria. 2 DOSAGE AND ADMINISTRATION 2.1 Dosage for Asthma . Administer XOLAIR 75 mg to 375 mg by subcutaneous injection every 2 or 4 weeks. Determine dose (mg) and dosing frequency by serum total IgE level (IU/mL) measured
    Status:unknown

Report Your Problem